Mallika Alvala

10PUBLICATIONS
10CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsGlycoconjugatesMedical biotechnology diagnostics (incl. biosensors)Biomolecular modelling and designCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 09, 2026
Rational Substitution-Driven Enhancement of Anti-Mycobacterium tuberculosis Activity in a Quinoline-Isonicotinic Acid Hydrazide Hybrid.

|Nov 19, 2024
Sugar mimics and their probable binding sites: design and synthesis of thiazole linked coumarin-piperazine hybrids as galectin-1 inhibitors.

Aaftaab Sethi, Janish Kumar, Divya Vemula

|May 08, 2024
Confronting Tuberculosis: A Synthetic Quinoline-Isonicotinic Acid Hydrazide Hybrid Compound as a Potent Lead Molecule Against Mycobacterium tuberculosis.

Govinda Raju Vadankula, Vipul V Nilkanth, Arshad Rizvi

|Apr 12, 2024
Design and synthesis of novel coumarin-benzimidazole hybrids as human galectin-1 inhibitors.

Sridhar G Nerella, Ravi Alvala, Arunasree M Kalle

|May 06, 2022
Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies.

Aaftaab Sethi, Swetha Sanam, Sharon Munagalasetty

|Oct 18, 2021
MEMES: Machine learning framework for Enhanced MolEcular Screening.

Sarvesh Mehta, Siddhartha Laghuvarapu, Yashaswi Pathak

Pageof 2

Frequent Collaborators

2 joint publications

Govinda Raju Vadankula

2 joint publications

Mohammed Arifuddin

2 joint publications

Sharmistha Banerjee

1 joint publications

Shekhar C Mande